Disposiciones Económicas

Paraguay

M. A. Khan J. B. Northwood R. G. J. Loor A. T. R. Tholen E. Riera M. Falcon

Paraguayan Antimicrobial Network A. van Belkum

M. van Westreenen J. P. Hays

Clin Microbiol Infect. 2009 Jul 20.

[Epub ahead of print]

Abstract

Forty infection-associated VanA-type vancomycin-resistant Enterococcus faecium (VRE) strains obtained from five collaborating hospitals in Asunción, Paraguay were investigated. Genotyping using pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing revealed the presence of 17 cluster types and four STs, with 93% (37/40) of isolates comprising ST type 78. Other ST types included ST-132, ST-210 and one new ST type (ST-438). All but one isolate (ST-438) were associated with clonal complex 17 (CC17), and 97% of the total isolates carried the esp gene. Three Tn1546 variants were found, including a new lineage containing an ISEfa5 insertion in an existing IS1251 element.

Vancomycin-resistant Enterococci (VRE) are nosocomial pathogens widely disseminated within hospitals [1], with the vanA genotype being the most common type of acquired glycopeptide resistance found in these enterococci. Although the first clinical isolate of VRE was detected in Europe in 1986, studies have now shown that clinical VRE may be isolated in several world regions [2]. Further, it is currently accepted that a single focal group of vanA-type VRE (clonal complex 17 or CC17) is particularly associated with nosocomial infections [3]. However, there is some evidence to suggest that this grouping may be influenced by the high rates of recombination associated with E. faecium [4].

In 1988, French researchers identified a small mobile genetic element in VanA-type Enterococcus faecium called Tn1546, which is involved in vancomycin resistance [5], and there are currently five other acquired vancomycin resistance genotypes reported in enterococci, namely vanB, vanD, vanE, vanG and vanL [5, 6].

Currently, there exist limited data regarding the incidence and types of clinical vancomycin-resistant E. faecium from countries in South America. Therefore, the objective of this study was to investigate the complexity of clinical E. faecium isolates from Paraguay, by determining E. faecium genotypes and VanA Tn1546 transposon diversity, and to compare the results with isolates from both South America and the rest of the world.

Two hundred and twenty-one VanA vancomycin-resistant E. faecium isolates were collected between January 2005 and March 2007 from five collaborating hospitals in Asunción Paraguay. These five hospitals, the Instituto de Previsión Social (IPS), Hospital de Clinicas (HCL), Hospital Nacional (HNA), Centro Medico de Bautista (CMB) and Instituto de Medicina Tropical (IMT), are representative of the national healthcare system in Paraguay.

A subset of 40 isolates was chosen for further analysis, based on their site of isolation and association with disease. These infection-associated isolates were cultured from abscess material, blood, tissue and needle aspirates, representing 7% (7/97), 20% (1/5) and 27%

(32/117) of the isolates obtained from HCL, HNA, and IPS, respectively. No infection-associated isolates were obtained from CMB (0/1) and IMT (0/1) hospitals.

Antibiotic resistance profiling was performed using the VITEK 2 system (BioMérieux, Marcy l’Étoile, France) and E-test (amoxicillin/clavulanic acid), according to CLSI guidelines. All 40 infection-associated isolates tested in this study were resistant to ampicillin, amoxicillin/clavulanic acid, ciprofloxacin, erythromycin, imipenem, penicillin, teicoplanin and vancomycin. All isolates were sensitive to linezolid and tetracycline. Forty-three per cent (17/40) of the isolates were resistant to gentamicin (Figure. 1).

The enterococcal surface protein gene (esp) was detected by PCR screening [7], revealing that all isolates were esp positive with the exception of one isolate (ST132). The prevalence of esp in these isolates is higher than previously reported for European CC17 isolates [8].

Pulsed-field gel electrophoresis (PFGE) and multi locus sequence typing (MLST) genotyping were performed as previously described [9]. PFGE results revealed 17 cluster types with no identifiable yearly pattern per cluster. Cluster analysis was performed using the method of DICE with UPGMA, with band tolerance set at 1.5% and the threshold cut-off value at 80% [10, 11]. The results of MLST genotyping revealed three known (78, ST-132 and ST-210) and one novel (ST-438) ST type, with 93% (36/40) of isolates comprising ST-78 genotypes. These ST-78 isolates comprised 100% of all infection-associated isolates from the HCL and HNA hospitals, and 87% (28/32) of the isolates from the IPS. Although this ST type has previously been reported in Europe, it has not been reported in South America, the USA or Spain, approximately 95% of Paraguayans are of mixed Spanish and Amerindian descent. Therefore, the origins of ST-78 in Paraguay remain unexplained, although it appears that the ST-78 strain has spread to many hospitals in Asunción.

In total, 97% (39/40) of the isolates tested belonged to MLST clonal complex 17 (CC17), which comprises a cluster of E. faecium genotypes previously associated with

hospital infections [3, 12]. ST-438 was the only non-CC17 isolate recovered. Further analysis revealed no association between the antibiotic resistance profile and PFGE or MLST genotypes (Figure. 1).

Characterization of Tn1546 was performed using previously published primers [13], and a touchdown PCR thermocycling protocol [7]. PCR primer walking and sequencing were used to define insertion site-specific sequences. The results of Tn1546 characterization revealed three different variants (Figure. 2). Two of the isolates did not show any insertion or deletion compared with the classic Tn1546 (BM4147) transposon sequence [14]. In contrast, 92% (37/40) of the isolates carried a Tn1546 variant containing an insertion of IS1216V (and a resultant deletion event) in orf1, coupled to an IS1251 insertion in the intergenic region of vanS and vanH (Tn1546 type F1 described by Willems et al. [15]). A single isolate with a new MLST genotype (ST-438) carried a novel Tn1546 variant of type F1 containing an ISEfa5 insertion. This IS element has only previously been described in Brazilian E. faecium isolates, where the ISEfa5 was exclusively inserted in the intergenic region of vanX and vanY [16]. In this ST-438 Paraguayan isolate the ISEfa5 element was inserted in the left flanking region of another insertion element IS1251, which itself was situated in the intergenic region between vanS and vanH. Sequencing of the ISEfa5 flanking insertion regions showed an inverted repeat of 6 bp (AGAGCC) flanked by an 8 bp direct repeat (AGAATAAT) of the IS1251 insertion element. From current evidence, presence of the ISEfa5 element in Tn1546 appears to be specific for Enterococcus isolates originating in South America. Further, this unusual insertion event indicates that Tn1546 may still be evolving in South American E. faecium isolates.

This is the first report of molecular investigations into vancomycin-resistant E.

faecium from Paraguay. The results from 40 infection-associated VRE isolates obtained from hospitals in Asunción revealed that the majority of isolates were found to be MLST type ST-78, a genotype associated with MLST clonal complex 17 (hospital-associated) isolates. The majority of isolates also carried the same Tn1546 structural variant (type F1), indicating that this combination currently represents the majority of infection-associated VanA E. faecium isolates currently circulating in hospitals in Asunción, Paraguay [15]. Also, although relatively little information is currently available, there appears to be an association between Tn1546/ISEfa5 and enterococcal isolates circulating in South America.

Acknowledgements

The authors would like to acknowledge W. Goessens and E. Dullart of the routine microbiology laboratory of the Erasmus MC and N Zarate from Laboratorio Central de

Salud Publica, Asunción, Paraguay for their assistance.

Dice (Tol 1.5%-1.5%) (H>0.0% S>0.0%) [0.0%-100.0%]

4 Paraguay VRE 24.02.09 Key 1146

Isolate Hospital Date ERY GEN NIT Q/D STR

100

Dice (Tol 1.5%-1.5%) (H>0.0% S>0.0%) [0.0%-100.0%]

Paraguay VRE 24.02.09

4 Paraguay VRE 24.02.09 Key 1146

Isolate Hospital Date ERY GEN NIT Q/D STR

100

Figure 1. Pulsed-field gel electrophoresis (PFGE) patterns obtained from 40 infection-associated vancomycin-resistant Enterococcus faecium isolates obtained from Paraguay between 2005 and 2007. Cluster analysis was performed using the method of DICE with UPGMA with band tolerance set to 1.5%.

orf1 orf2 vanR vanS vanH vanA vanX vanY vanZ

A1

F1*

BM4147

F1

IS1251

5820 5813

889 bp deletion IS1216V

619bp pEFNP1-fragment

889 bp deletion IS1216V

619bp pEFNP1-fragment

Group (2)

(37)

(1)

IS1251

5820 5813

45 ISEfa538

No of isolates

orf1 orf2 vanR vanS vanH vanA vanX vanY vanZ

A1

F1*

BM4147

F1

IS1251

5820 5813

889 bp deletion IS1216V

619bp pEFNP1-fragment

889 bp deletion IS1216V

619bp pEFNP1-fragment

Group (2)

(37)

(1)

IS1251

5820 5813

45 ISEfa538

No of isolates

Figure 2. PCR and sequence-based characterization of Tn1546 in 40 infection-related Enterococcus faecium isolates from Paraguay. Tn1546 reference sequence BM4147 is represented by the unbroken black lines. The position of different genes and open reading frames (orf1 and orf2) are shown by filled block arrows. IS elements are shown by filled boxes and their direction of transcription is represented by arrows. Deletions are represented by dotted lines. The positions of the first nucleotides upstream and downstream of the insertion sequences are shown. The groups are based on the published results of Willems et al. [15]. *A novel F1 variant of Tn1546. Numbers on the left indicate how many isolates were found to belong to each Tn1546 variant.

References

1. Bonten MJ, Willems R, Weinstein RA. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1: 314–325.

2. Top J, Willems R, Bonten M. Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol 2008; 52:

297–308.

3. Willems RJ, Top J, van Santen M et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005; 11: 821–828.

4. Turner KM, Hanage WP, Fraser C et al. Assessing the reliability of eBURST using simulated populations with known ancestry. BMC Microbiol 2007; 7: 30.

5. Courvalin P. Vancomycin resistance in gram-positive cocci. Clin Infect Dis 2006; 42 (suppl 1): S25–S34.

6. Boyd DA, Willey BM, Fawcett D et al. Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob Agents Chemother 2008; 52: 2667–2672.

7. Khan MA, van der Wal M, Farrell DJ et al. Analysis of VanA vancomycin-resistant Enterococcus faecium isolates from Saudi Arabian hospitals reveals the presence of clonal cluster 17 and two new Tn1546 lineage types. J Antimicrob Chemother 2008; 62: 279–283.

8. Top J, Willems R, van der Velden S et al. Emergence of clonal complex 17 Enterococcus faecium in The Netherlands. J Clin Microbiol 2008; 46: 214–219.

9. Homan WL, Tribe D, Poznanski S et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 2002; 40: 1963–1971.

10. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233–2239.

11. Carrico JA, Pinto FR, Simas C et al. Assessment of band-based similarity coefficients for automatic type and subtype classification ofmicrobial isolates analyzed by pulsed-field gel electrophoresis. J Clin Microbiol 2005; 43: 5483–5490.

12. Leavis HL, Bonten MJ, Willems RJ. Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance. Curr Opin Microbiol 2006; 9:

454–460.

13. Miele A, Bandera M, Goldstein BP. Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrob Agents Chemother 1995; 39: 1772–1778.

14. Arthur M, Molinas C, Depardieu F et al. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993; 175:

117–127.

15. Willems RJ, Top J, van den Braak N et al. Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals.

Antimicrob Agents Chemother 1999; 43: 483–491.

16. Camargo IL, Zanella RC, Brandileone MC et al. Occurrence of insertion sequences within the genomes and Tn1546-like elements of glycopeptide-resistant enterococci isolated in Brazil, and identification of a novel element, ISEfa5. Int J Med Microbiol 2005; 294: 513–519.

Molecular epidemiology of high-level aminoglycoside resistant